Evidence map›Paper›PMID 26411797›Full record

ArticleScientific reports2015

Human Induced Pluripotent Stem Cell Derived Neuronal Cells Cultured on Chemically-Defined Hydrogels for Sensitive In Vitro Detection of Botulinum Neurotoxin.

Sabine Pellett, Michael P Schwartz, William H Tepp, Richard Josephson, Jacob M Scherf, Christina L Pier, James A Thomson, William L Murphy, Eric A Johnson

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Why the impact of mechanical stimuli on stem cells remains a challenge.Cellular and molecular life sciences : CMLS · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sabine PellettDepartment of Bacteriology, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
Michael P SchwartzDepartment of Biomedical Engineering, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
William H TeppDepartment of Bacteriology, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
Richard JosephsonMTI-GlobalStem, Inc. Gaithersburg, Maryland, United States of America.
Jacob M ScherfDepartment of Bacteriology, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
Christina L PierDepartment of Bacteriology, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
James A ThomsonDepartment of Cell and Regenerative Biology, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
William L MurphyDepartment of Biomedical Engineering, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
Eric A JohnsonDepartment of Bacteriology, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.
University of Wisconsin–Madison · USMorgridge Institute for Research · US

Funding

Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning.R01AI093504 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Konstantin Ichtchenko · 2011 to 2026
$13.9M
Retinal tissue chips for ocular disease modelingUH3TR000506 · NCATS · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI THOMSON, JAMES ALEXANDER · 2014 to 2016
$6.2M
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and TeratogenicityUH2TR000506 · NCATS · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI THOMSON, JAMES ALEXANDER · 2012 to 2013
$2.4M
Characterization of Botulinum Neurotoxin A SubtypesR01AI095274 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON, ERIC A. · 2012 to 2016
$2.0M
Probing biochemical/biophysical influences on endothelial-mesenchymal transitionR21EB016381 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI MURPHY, WILLIAM L., SCHWARTZ, MICHAEL PAUL · 2013 to 2014
$399k
NCATS NIH HHS 1UH2TR000506-01NCATS NIH HHS 3UH2TR000506-02S1NCATS NIH HHS UH2 TR000506NCATS NIH HHS UH3 TR000506NIAID NIH HHS R01 AI093504NIAID NIH HHS R01AI093504NIAID NIH HHS R01 AI095274NIAID NIH HHS R01AI095274NIBIB NIH HHS R21 EB016381NIBIB NIH HHS R21EB016381-01
6 · The paper itself

Abstract

Botulinum neurotoxin (BoNT) detection provides a useful model for validating cell-based neurotoxicity screening approaches, as sensitivity is dependent on functionally competent neurons and clear quantitative endpoints are available for correlating results to approved animal testing protocols. Here, human induced pluripotent stem cell (iPSC)-derived neuronal cells were cultured on chemically-defined poly(ethylene glycol) (PEG) hydrogels formed by "thiol-ene" photopolymerization and tested as a cell-based neurotoxicity assay by determining sensitivity to active BoNT/A1. BoNT/A1 sensitivity was comparable to the approved in vivo mouse bioassay for human iPSC-derived neurons and neural stem cells (iPSC-NSCs) cultured on PEG hydrogels or treated tissue culture polystyrene (TCP) surfaces. However, maximum sensitivity for BoNT detection was achieved two weeks earlier for iPSC-NSCs that were differentiated and matured on PEG hydrogels compared to TCP. Therefore, chemically-defined synthetic hydrogels offer benefits over standard platforms when optimizing culture conditions for cell-based screening and achieve sensitivities comparable to an approved animal testing protocol.

Indexed as

AnimalsBotulinum ToxinsBotulinum Toxins, Type ACell DifferentiationCells, CulturedDrug DiscoveryDrug Evaluation, PreclinicalHumansHydrogelsInduced Pluripotent Stem CellsMiceNeuronsPolyethylene GlycolsBotulinum ToxinsBotulinum Toxins, Type AHydrogelsPolyethylene Glycols

Identifiers

PMID26411797
PMCPMC4585966
OpenAlexW2416542268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.